Across TCGA pan-cancer cohorts, BIN2P2 RNA differs between tumor and matched normal tissue in 1 of 18 cancer types tested, making tumor–normal expression one of BIN2P2’s most consistent transcriptional readouts.
The strongest signal is observed in lung squamous cell carcinoma (LUSC), where BIN2P2 RNA is repressed in tumor relative to normal tissue. In most cancer types BIN2P2 is over-expressed in tumor, although a few such as LUSC show the opposite, repressed pattern.
LUSC are the cancer types where BIN2P2 tumor–normal differential expression is most reproducible.